Objective: To review and discuss key aspects of the drug therapy recommendations in the
American College of Cardiology (ACC)/American Heart Association (AHA) 2005 Guideline …

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization,
poor quality of life, and multiple comorbidities. As a result, heart failure management …

1.1. Evidence Review Late-breaking clinical trials presented at the 2005, 2006, and 2007
annual scientific meetings of the ACCF, AHA, and European Society of Cardiology, as well …

Chronic heart failure (CHF) is associated with a high burden of mortality and morbidity and is
the leading principal hospital diagnosis among older adults. As a result of the complexities …

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization,
reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is …

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization,
reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is …

Late-breaking clinical trials presented at the 2005, 2006, and 2007 annual scientific
meetings of the ACCF, AHA, and European Society of Cardiology, as well as selected other …

Heart failure (HF) is a major public health problem, and it is associated with increased
morbidity and mortality. As the US life expectancy increases and the population ages, the …

Guidelines The last 10–15 years have been a period of tremendous advances in many fields
of clinical medicine and have seen the publication of large numbers of randomized clinical …

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization,
reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is …